Hogan Lovells advised CatalYm GmbH on the deal. CatalYm GmbH, a Munich-based life sciences company, completed a significant USD150 million venture capital funding round. The oversubscribed...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised global healthcare company Fresenius Kabi AG on the deal. Prange Group and its affiliate Adragos Pharma signed a definitive agreements with Fresenius Kabi...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised Bavarian CatalYm GmbH on the deal. CatalYm GmbH raised €50 million through its Series-C financing round. The oversubscribed round was co-led by new...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Eli Lilly and Company on the matter. Eli Lilly and Company was involved in a tender process and associated framework agreement with the...
You must be a Standard 1 Year member to access this content.
Hogan Lovells and Gross GKH advised Merz Therapeutics on the deal. Merz Therapeutics, a business of Merz Pharmaceuticals GmbH and part of the Merz Group, and...
You must be a Standard 1 Year member to access this content.
Hogan Lovells represented Intellia Therapeutics on the matter. Intellia Therapeutics launched a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company in a...
You must be a Standard 1 Year member to access this content.
